Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population

Clinical trial NCT02385058 · COMPLETED

Trial details

NCT number: NCT02385058
Sponsor: Janssen-Cilag Ltd.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Helminthiasis Amoebiasis

Start date: 2005-10-01
Primary completion: 2006-01-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.